Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
White House unveils next round of MFN drug pricing deals
At the dealmaking table this time are Alcon, Astellas, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva and UCB.
Fraiser Kansteiner
Aug 31, 2026 5:10pm
Ascendis pays 20% royalties in patent settlement with BioMarin
Aug 31, 2026 1:56pm
Why real-world data is becoming a strategic asset in drug development
Brought to you by
LabCorp
Jazz’s Ziihera secures 2nd survival win in HER2+ stomach cancer
Aug 31, 2026 10:17am
Pharma Doesn't Have an AI Problem. It Has an Information Problem.
Brought to you by
Intelligencia AI
FDA approves label expansion for PharmaEssentia's Besremi
Aug 31, 2026 8:25am
